Vioxx Hearing May Be Sign Of Things To Come Under Medicare Rx
Executive Summary
The Senate Finance Committee should continue to review FDA's drug safety procedures in light of the upcoming expansion of the Medicare program, Ranking Democrat Max Baucus (D-Mont.) maintained during the committee's Nov. 18 hearing on Vioxx
You may also be interested in...
Senate Health Committee Adds Republican Sens. Burr, Hatch
Sen.-elect Richard Burr (R-N.C.) will bring a long history of involvement in prescription drug issues to the Senate Health Committee in the 109th Congress
Senate Health Committee Adds Republican Sens. Burr, Hatch
Sen.-elect Richard Burr (R-N.C.) will bring a long history of involvement in prescription drug issues to the Senate Health Committee in the 109th Congress
Senate Health Cmte. Drug Safety Focus Will Be Antidepressants, Not Vioxx
The Senate Health Committee's oversight of FDA's drug safety regulation is likely to focus on the agency's handling of antidepressants